CME Group Inc. (NASDAQ:CME – Get Free Report) CEO Terrence Duffy sold 27,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 18th. The shares were sold at an average price of $309.57, for a total value of $8,358,390.00. Following the completion of the transaction, the chief executive officer directly owned 35,442 shares of the company’s stock, valued at $10,971,779.94. The trade was a 43.24% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.
CME Group Trading Up 0.4%
CME Group stock opened at $307.54 on Friday. The firm has a market cap of $110.08 billion, a PE ratio of 25.23, a P/E/G ratio of 3.75 and a beta of 0.15. CME Group Inc. has a 12 month low of $218.31 and a 12 month high of $329.16. The stock’s 50 day simple moving average is $289.43 and its two-hundred day simple moving average is $282.08. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13.
CME Group (NASDAQ:CME – Get Free Report) last posted its earnings results on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share for the quarter, beating the consensus estimate of $2.99 by $0.03. The firm had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.71 billion. CME Group had a net margin of 63.33% and a return on equity of 16.23%. The business’s quarterly revenue was up 10.6% on a year-over-year basis. During the same period in the previous year, the firm earned $2.68 EPS. Analysts anticipate that CME Group Inc. will post 12.36 earnings per share for the current year.
CME Group Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 30th. Investors of record on Friday, December 11th will be given a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 1.7%. The ex-dividend date is Friday, December 11th. CME Group’s dividend payout ratio (DPR) is currently 42.66%.
Institutional Investors Weigh In On CME Group
A number of institutional investors have recently added to or reduced their stakes in the stock. Brookmont Capital Management lifted its holdings in CME Group by 0.6% during the third quarter. Brookmont Capital Management now owns 5,661 shares of the financial services provider’s stock valued at $1,483,000 after purchasing an additional 34 shares in the last quarter. Harbour Wealth Management Group Inc. grew its position in shares of CME Group by 1.6% in the third quarter. Harbour Wealth Management Group Inc. now owns 2,216 shares of the financial services provider’s stock valued at $581,000 after purchasing an additional 34 shares during the period. Manchester Capital Management LLC increased its stake in shares of CME Group by 2.9% during the third quarter. Manchester Capital Management LLC now owns 1,297 shares of the financial services provider’s stock worth $340,000 after purchasing an additional 37 shares in the last quarter. Grove Bank & Trust increased its stake in shares of CME Group by 0.8% during the third quarter. Grove Bank & Trust now owns 5,038 shares of the financial services provider’s stock worth $1,320,000 after purchasing an additional 39 shares in the last quarter. Finally, Intrua Financial LLC raised its position in shares of CME Group by 3.0% during the 3rd quarter. Intrua Financial LLC now owns 1,334 shares of the financial services provider’s stock worth $350,000 after purchasing an additional 39 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.
CME Group News Summary
Investors following CME have been watching these news items:
- Positive Sentiment: CME reported that XRP and Micro XRP futures generated $81.2 billion in notional volume across roughly 18 months, averaging $216 million per day through mid-November. Strong activity may support transaction and clearing revenue. Article
- Positive Sentiment: The company announced the first trade in its wind power contracts, extending its product lineup and potentially opening another market for trading and risk management. Article
- Negative Sentiment: CEO Terrence Duffy sold 27,000 shares, reducing his direct holdings by about 43%; General Counsel John Marchese also sold 655 shares. Insider sales can be for personal reasons and do not necessarily signal weaker prospects, but may weigh on sentiment. CEO sale report General counsel sale report
Analyst Upgrades and Downgrades
CME has been the subject of a number of analyst reports. Weiss Ratings upgraded shares of CME Group from a “buy (b)” rating to a “buy (b+)” rating in a research report on Friday, November 13th. TD Cowen increased their target price on shares of CME Group from $292.00 to $300.00 and gave the stock a “buy” rating in a research note on Monday, October 5th. Barclays raised their target price on CME Group from $281.00 to $321.00 and gave the company an “equal weight” rating in a research report on Thursday, October 22nd. UBS Group lifted their price target on CME Group from $270.00 to $310.00 and gave the company a “neutral” rating in a research note on Thursday, October 22nd. Finally, Wall Street Zen raised CME Group from a “sell” rating to a “hold” rating in a report on Saturday, October 31st. Ten equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, CME Group has an average rating of “Hold” and a consensus target price of $314.44.
View Our Latest Stock Report on CME Group
CME Group Company Profile
CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.
Recommended Stories
- Five stocks we like better than CME Group
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
